X‐linked Opitz syndrome: Novel mutations in the MID1 gene and redefinition of the clinical spectrum
- 16 January 2003
- journal article
- case report
- Published by Wiley in American Journal of Medical Genetics Part A
- Vol. 120A (2) , 222-228
- https://doi.org/10.1002/ajmg.a.10265
Abstract
Opitz (or G/BBB) syndrome is a pleiotropic genetic disorder characterized by hypertelorism, hypospadias, and additional midline defects. This syndrome is heterogeneous with an X‐linked (XLOS) and an autosomal dominant (ADOS) form. The gene implicated in the XLOS form, MID1, encodes a protein containing a RING‐Bbox‐Coiled‐coil motif belonging to the tripartite motif (TRIM) family. To further clarify the molecular basis of XLOS, we have undertaken mutation analysis of the MID1 gene in patients with Opitz syndrome (OS). We found novel mutations in 11 of 63 male individuals referred to us as sporadic or familial X‐linked OS cases. The mutations are scattered throughout the gene, although more are represented in the 3′ region. By reviewing all the MID1‐mutated OS patients so far described, we confirmed that hypertelorism and hypospadias are the most frequent manifestations, being present in almost every XLOS individual. However, it is clear that laryngo‐tracheo‐esophageal (LTE) defects are also common anomalies, being manifested by all MID1‐mutated male patients. Congenital heart and anal abnormalities are less frequent than reported in literature. In addition, we can include limb defects in the OS clinical synopsis as we found a MID1‐mutated patient showing syndactyly. The low frequency of mutations in MID1 and the high variability of the phenotype suggest the involvement of other genes in the OS phenotype.Keywords
Funding Information
- Italian Telethon Foundation
- March of Dimes Birth Defects Foundation
This publication has 18 references indexed in Scilit:
- Phosphorylation and microtubule association of the Opitz syndrome protein mid-1 is regulated by protein phosphatase 2A via binding to the regulatory subunit α4Proceedings of the National Academy of Sciences, 2001
- New mutations in MID1 provide support for loss of function as the cause of X-linked Opitz syndromeHuman Molecular Genetics, 2000
- Functional Characterization of the Opitz Syndrome Gene Product (Midin): Evidence for Homodimerization and Association With Microtubules Throughout the Cell CycleHuman Molecular Genetics, 1999
- Opitz G/BBB Syndrome in Xp22: Mutations in the MID1 Gene Cluster in the Carboxy-Terminal DomainAmerican Journal of Human Genetics, 1998
- Further delineation of the Opitz G/BBB syndrome: Report of an infant with complex congenital heart disease and bladder exstrophy, and review of the literatureAmerican Journal of Medical Genetics, 1998
- Recommendations for a nomenclature system for human gene mutationsHuman Mutation, 1998
- CNS midline anomalies in the opitz G/BBB syndrome: Report on 12 Brazilian patientsAmerican Journal of Medical Genetics, 1992
- Opitz (BBB/G) syndrome: Oral manifestationsAmerican Journal of Medical Genetics, 1992
- The opitz syndrome: A new designation for the clinically indistinguishable BBB and G syndromesAmerican Journal of Medical Genetics, 1987
- Phenotypic overlap of the BBB and G syndromesAmerican Journal of Medical Genetics, 1978